1. Home
  2. SLNO vs TFPM Comparison

SLNO vs TFPM Comparison

Compare SLNO & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • TFPM
  • Stock Information
  • Founded
  • SLNO 1999
  • TFPM 2016
  • Country
  • SLNO United States
  • TFPM Canada
  • Employees
  • SLNO N/A
  • TFPM N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TFPM Precious Metals
  • Sector
  • SLNO Health Care
  • TFPM Industrials
  • Exchange
  • SLNO Nasdaq
  • TFPM Nasdaq
  • Market Cap
  • SLNO 3.8B
  • TFPM 4.3B
  • IPO Year
  • SLNO 2014
  • TFPM N/A
  • Fundamental
  • Price
  • SLNO $86.00
  • TFPM $23.02
  • Analyst Decision
  • SLNO Strong Buy
  • TFPM Strong Buy
  • Analyst Count
  • SLNO 9
  • TFPM 3
  • Target Price
  • SLNO $105.11
  • TFPM $23.67
  • AVG Volume (30 Days)
  • SLNO 1.5M
  • TFPM 420.4K
  • Earning Date
  • SLNO 08-06-2025
  • TFPM 08-06-2025
  • Dividend Yield
  • SLNO N/A
  • TFPM 0.95%
  • EPS Growth
  • SLNO N/A
  • TFPM N/A
  • EPS
  • SLNO N/A
  • TFPM 0.02
  • Revenue
  • SLNO N/A
  • TFPM $293,708,000.00
  • Revenue This Year
  • SLNO N/A
  • TFPM $27.78
  • Revenue Next Year
  • SLNO $506.77
  • TFPM $0.71
  • P/E Ratio
  • SLNO N/A
  • TFPM $948.06
  • Revenue Growth
  • SLNO N/A
  • TFPM 39.01
  • 52 Week Low
  • SLNO $41.50
  • TFPM $13.94
  • 52 Week High
  • SLNO $90.32
  • TFPM $25.45
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 54.38
  • TFPM 44.93
  • Support Level
  • SLNO $83.53
  • TFPM $23.15
  • Resistance Level
  • SLNO $89.12
  • TFPM $23.63
  • Average True Range (ATR)
  • SLNO 2.65
  • TFPM 0.51
  • MACD
  • SLNO -0.34
  • TFPM -0.10
  • Stochastic Oscillator
  • SLNO 56.91
  • TFPM 24.56

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

Share on Social Networks: